The Next Few Days Could Get VERY Interesting…
2 extracted signals · 1 resolved · 1 still active
StockedUpIndependent analyst profile- Source published
- 22 Sept 2026, 22:00 UTC
- Recorded by Tahlil Plus
- 23 Sept 2026, 01:40 UTC
AI-generated source summary
The analysis covers several key market movements and potential setups. SPY is identified as being in a downtrend within a channel, but with a recent bounce off support and a bullish MACD crossover near all-time highs, suggesting a potential upward move targeting resistance at 450, with a fail bound below 390. MRNA has shown explosive upward momentum, currently trading near its all-time highs, with a strong bullish prediction underpinned by recent positive news regarding its cancer vaccine trials. A potential target is set at 200, with a fail bound below 167. CRNA and AG are also showing bullish momentum and have broken out of previous downtrends or are testing key resistance levels. CRNA has seen a significant short-term rise, and is nearing a multi-year resistance zone. AG has also shown strength, with a potential target around 25, failing below 17.50. The overall market sentiment appears cautiously optimistic for select assets, despite broader market concerns.
AI-generated summary based on the source content.
Signal outcomes at a glance
Partially ResolvedSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
1 signal remains active.
StockedUp
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.